. Overview We are cultivating a differentiated neuroscience company, rooted in innovation and driven by a commitment to addressing the unmet needs of patients living with neurological diseases. To date, we have focused on rare neurological diseases with a growing portfolio now spanning sleep/wake, rare epilepsy, and neurobehavioral and we are harnessing scientific insights and pioneering approaches to advance meaningful treatments that help patients thrive. In July 2017, we entered into a Licens...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-31 | 0001104659-26-018859 | EDGAR | 91K words |
| 2025-02-25 | 2024-12-31 | 0001558370-25-001441 | EDGAR | — |
| 2024-02-22 | 2023-12-31 | 0001558370-24-001466 | EDGAR | — |
| 2023-02-21 | 2022-12-31 | 0001558370-23-001574 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001558370-22-002257 | EDGAR | — |
| 2021-03-25 | 2020-12-31 | 0001564590-21-015274 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-04 | 2025-09-30 | 0001104659-25-105962 | EDGAR | 27K words |
| 2025-08-05 | 2025-06-30 | 0001558370-25-010185 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0001558370-25-006394 | EDGAR | — |
| 2024-10-29 | 2024-09-30 | 0001558370-24-013803 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001558370-24-010956 | EDGAR | — |
| 2024-04-30 | 2024-03-31 | 0001558370-24-006203 | EDGAR | — |
| 2023-10-31 | 2023-09-30 | 0001558370-23-017060 | EDGAR | — |
| 2023-08-01 | 2023-06-30 | 0001558370-23-012637 | EDGAR | — |
| 2023-05-02 | 2023-03-31 | 0001558370-23-007571 | EDGAR | — |
| 2022-11-01 | 2022-09-30 | 0001558370-22-015726 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0001558370-22-011556 | EDGAR | — |
| 2022-05-03 | 2022-03-31 | 0001558370-22-006729 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-02 | 0001104659-26-038888 | EDGAR | 9K words |
| 2026-02-24 | 0001104659-26-018858 | EDGAR | — |
| 2026-01-12 | 0001104659-26-002731 | EDGAR | — |
| 2025-11-04 | 0001104659-25-105942 | EDGAR | — |
| 2025-10-23 | 0001104659-25-101688 | EDGAR | — |
| 2025-09-24 | 0001104659-25-092776 | EDGAR | — |
| 2025-08-05 | 0001558370-25-010182 | EDGAR | — |
| 2025-06-11 | 0001558370-25-008525 | EDGAR | — |
| 2025-06-05 | 0001558370-25-008415 | EDGAR | — |
| 2025-05-15 | 0001558370-25-007894 | EDGAR | — |
106 total filings indexed. 78 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001802665 |
| Ticker | HRMY |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.harmonybiosciences.com |
| Listed | 2020-08-19 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report